AbCellera Biologics (ABCL) Net Margin (2020 - 2026)
AbCellera Biologics (ABCL) posted Net Margin of 519.12% for Q1 2026, down 2503.04% on a QoQ basis from 19.94% in Q4 2025, and up 55812.0% year-over-year from N/an in Q1 2025.
AbCellera Biologics (ABCL) Net Margin (2020 - 2026) Analysis & Trends
AbCellera Biologics' Net Margin history runs 7 years deep, the most recent figure standing at 519.12% for Q1 2026.
- Quarterly Net Margin rose 55812.0% year-over-year to 519.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 181.75% (up 54448.0% YoY) and the FY2025 annual result came in at 194.88%, up 36995.0% from the prior year.
- Net Margin was 519.12% for Q1 2026 at AbCellera Biologics, down from 19.94% in the prior quarter.
- Across five years, Net Margin topped out at 53.25% in Q1 2022 and bottomed at 1077.24% in Q1 2025.
- A 5-year average of 381.55% and a median of 407.98% in 2024 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 65748 bps in 2025, while the deepest fall reached 66926 bps in 2025.
- AbCellera Biologics' Net Margin stood at 138.75% in 2022, then slumped by 270 bps to 513.67% in 2023, then slumped by 32 bps to 677.43% in 2024, then jumped by 97 bps to 19.94% in 2025, then sank by 2503 bps to 519.12% in 2026.
- Business Quant data shows ABCL's Net Margin at 519.12% in Q1 2026, 19.94% in Q4 2025, and 637.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -519.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -519.12% |
| Dec 31, 2025 | -19.94% |
| Sep 30, 2025 | -637.84% |
| Jun 30, 2025 | -203.27% |
| Mar 31, 2025 | -1,077.24% |
| Dec 31, 2024 | -677.43% |
| Sep 30, 2024 | -785.42% |
| Jun 30, 2024 | -504.30% |
| Mar 31, 2024 | -407.98% |
| Dec 31, 2023 | -513.67% |
| Sep 30, 2023 | -433.55% |
| Jun 30, 2023 | -303.58% |
| Mar 31, 2023 | -328.99% |
| Dec 31, 2022 | -138.75% |
| Sep 30, 2022 | 26.26% |
| Jun 30, 2022 | -14.78% |
| Mar 31, 2022 | 53.25% |
| Dec 31, 2021 | 43.03% |
| Sep 30, 2021 | -388.16% |
| Jun 30, 2021 | -8.40% |